Deal Library / Pharma BD Deal Intelligence

Pfizer Inc. — Pharma Deals

The Pharma Closeout tracks 61 deals, $882.5B in disclosed deal value, 44 with a post-close Outcome Score for Pfizer Inc..

Median Critic Score: 75  ·  Median Outcome Score: 52

Best outcome: Pfizer Inc. / BioNTech SE (100)  ·  Weakest outcome: Pfizer Inc. / Medivation, Inc. (9)

All 61 deals

• Pfizer Inc. / BioNTech SE — 2020 · $748M · Worked — the deal delivered on its rationale.
• Pfizer Inc. / FoldRx Pharmaceuticals — 2010 · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Medivation Inc. — 2016 · $14.0B · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Wyeth — 2009 · $68.0B · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Warner-Lambert Company — 2000 · $90.0B · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Seagen Inc. — 2023 · $43.0B · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Arvinas, Inc. — 2021 · $2.4B · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Baxter International Inc. (commercial vaccines portfolio) — 2014 · $635M · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Agouron Pharmaceuticals — 1999 · $2.1B · Largely worked — most objectives met.
• Pfizer Inc. / Array BioPharma Inc. — 2019 · $11.4B · Largely worked — most objectives met.
• Pfizer Inc. / Innovent Biologics, Inc. — 2026 · $10.5B · Largely worked — most objectives met.
• Pfizer Inc. / Capsugel (Pfizer divestiture to KKR) — 2011 · $2.4B · Largely worked — most objectives met.
• Pfizer Inc. / Biohaven Pharmaceutical Holding Company Ltd. — 2022 · $11.6B · Largely worked — most objectives met.
• Pfizer Inc. / Pharmacia Corporation — 2002 · $60.0B · Largely worked — most objectives met.
• Pfizer Inc. / Beam Therapeutics Inc. — 2022 · $1.4B · Largely worked — most objectives met.
• Pfizer Inc. / Arena Pharmaceuticals — 2021 · $6.7B · Largely worked — most objectives met.
• Pfizer Inc. / 3SBio Inc. — 2025 · $6.0B · Largely worked — most objectives met.
• Pfizer Inc. / Alacer Corp. — 2011 · Largely worked — most objectives met.
• Pfizer Inc. / Pharmacia Corporation — 2003 · $60.0B · Largely worked — most objectives met.
• Pfizer Inc. / BioNTech SE — 2018 · $425M · Mixed — partial payoff, real shortfalls.
• Pfizer Inc. / Merck KGaA — 2014 · $2.9B · Mixed — partial payoff, real shortfalls.
• Pfizer Inc. / Novavax Inc. — 2026 · $530M · Mixed — partial payoff, real shortfalls.
• Pfizer Inc. / CStone Pharmaceuticals — 2020 · $780M · Mixed — partial payoff, real shortfalls.
• Pfizer Inc. / Anacor Pharmaceuticals — 2016 · $5.2B · Underwhelmed — fell short of the thesis.
• Pfizer Inc. / Bioren, Inc. — 2005 · Underwhelmed — fell short of the thesis.
• Pfizer Inc. / InnoPharma, Inc. — 2014 · $360M · Underwhelmed — fell short of the thesis.
• Pfizer Inc. / Global Blood Therapeutics Inc. — 2022 · $5.4B · Did not work — the deal failed to deliver.
• Pfizer Inc. / Allergan, Inc. — 2015 · $160.0B · Did not work — the deal failed to deliver.
• Pfizer Inc. / AstraZeneca PLC — 2014 · $118.0B · Did not work — the deal failed to deliver.
• Pfizer Inc. / Vicuron Pharmaceuticals Inc. — 2004 · $1.9B · Did not work — the deal failed to deliver.
• Pfizer Inc. / Vicuron Pharmaceuticals, Inc. — 2005 · $1.9B · Did not work — the deal failed to deliver.
• Pfizer Inc. / Trillium Therapeutics Inc. — 2021 · $2.3B · Did not work — the deal failed to deliver.
• Pfizer Inc. / NextWave Pharmaceuticals, Inc. — 2012 · $700M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Rinat Neuroscience Corporation — 2006 · $500M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Icagen, Inc. — 2011 · $56M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Excaliard Pharmaceuticals, Inc. — 2011 · Did not work — the deal failed to deliver.
• Pfizer Inc. / PowderMed Ltd. — 2006 · $400M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Bamboo Therapeutics, Inc. — 2016 · $645M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Coley Pharmaceutical Group Inc. — 2007 · $164M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Esperion Therapeutics Inc. — 2003 · $1.3B · Did not work — the deal failed to deliver.
• Pfizer Inc. / Idun Pharmaceuticals, Inc. — 2005 · $298M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Medivation, Inc. — 2008 · $725M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Encysive Pharmaceuticals Inc. — 2008 · $195M · Did not work — the deal failed to deliver.
• Pfizer Inc. / Sanofi-Aventis (Exubera worldwide rights) — 2006 · $1.4B · Did not work — the deal failed to deliver.
• Pfizer Inc. / Metsera, Inc. — 2025 · $10.0B
• Pfizer Inc. / Adaptive Biotechnologies Corp. — 2025 · $890M
• Pfizer Inc. / Triana Biomedicines Inc. — 2024 · $1.5B
• Pfizer Inc. / Nona Biosciences (Harbour BioMed subsidiary) — 2023 · $1.1B
• Pfizer Inc. / Valneva SE (VLA15 collaboration update) — 2022 · $363M
• Pfizer Inc. / ReViral Ltd. — 2022 · $525M
• Pfizer Inc. / Vivet Therapeutics S.A.S. — 2020
• Pfizer Inc. / Valneva SE — 2020 · $308M
• Pfizer Inc. / Myovant Sciences Ltd. — 2020 · $4.2B
• Pfizer Inc. / Akcea Therapeutics / Ionis Pharmaceuticals (AKCEA-ANGPTL3-LRx license) — 2019 · $1.3B
• Pfizer Inc. / Vivet Therapeutics S.A.S. — 2019 · $635M
• Pfizer Inc. / Therachon Holding AG — 2019 · $810M
• Pfizer Inc. / Sangamo Therapeutics, Inc. — 2017 · $545M
• Pfizer Inc. / Allergan plc — 2016 · $160.0B
• Pfizer Inc. / Cellectis SA — 2014 · $2.9B
• Pfizer Inc. / Biocon Limited (biosimilar insulin license) — 2010 · $350M
• Pfizer Inc. / Protalix BioTherapeutics, Inc. — 2009 · $175M

← Deal Library  ·  Interactive search  ·  How we score deals